Directors & Officers

Directors
Audit & Supervisory Board Members
Executive Officers

As of April 1, 2025

OutsideOutside Director

IndependentIndependent officer pursuant to Article 436-2 of the regulations of Tokyo Stock Exchange, Inc.

Directors

	Dr. Osamu OkudaRepresentative Director, President & CEO In charge of Audit Department Profile Date of Birth April 5, 1963 1987 Joined the Company 2008 General Manager of Lifecycle Management Dept. II 2009 General Manager of Lifecycle Management Dept. II and Head of Lifecycle 2011 President of Roche Products (Ireland) Limited 2013 General Manager of Oncology Unit, Marketing & Sales Division 2014 Vice President, General Manager of Oncology Unit, Marketing & Sales Division 2015 Vice President, General Manager of Corporate Planning Department 2017 Executive Vice President, General Manager of Corporate Planning Department 2018 Executive Vice President, Co-Head of Project & Lifecycle Management Unit 2020 Representative Director, President & COO 2021 Representative Director, President & CEO (to present)
	Iwaaki TaniguchiDirector, Executive Vice President & CFO Head of Finance Supervisory Division Profile Date of Birth December 4, 1966 1989 Joined The Long-Term Credit Bank of Japan, Limited (currently SBI Shinsei Bank, Limited) 2004 Joined Takeda Pharmaceutical Company Limited (“Takeda”) 2013 General Manager of Corporate Finance Department of Takeda 2015 General Manager of Finance Management Department of Takeda 2017 Joined Recruit Holdings Co., Ltd. Corporate Executive Officer (Responsible for Finance) of Recruit Holdings Co., Ltd. 2018 Corporate Executive Officer (Responsible for Finance), of Recruit Holdings Co., Ltd. and Director of Recruit Co., Ltd. 2022 Joined the Company Senior Vice President, Head of Finance & Accounting Department 2023 Senior Vice President Head of Finance Supervisory Div. (to present) Head of Finance & Accounting Department 2024 Director, Executive Vice President & CFO (to present)
	Dr. Hitoshi IikuraDirector, Executive Vice President Head of Translational Research Division Profile Date of Birth February 26, 1970 2000 Joined the Company 2017 Head of Medicinal Chemistry Research Department 2021 Head of Research Division 2022 Vice President, Head of Research Division 2024 Vice President, Head of Translational Research Division
OutsideIndependent	Dr. Mariko Y Momoi Professor Emeritus of Jichi Medical University Invited Professor of School of Medicine, Shinshu University Regent of Tokyo Medical University (part-time) Profile Date of Birth February 24, 1948 1994 Head of Department of Pediatrics, Jichi Medical University 2006 Director of Jichi Children’s Medical Center Tochigi 2010 Dean of School of Medicine, Jichi Medical University 2012 Visiting Professor of School of Medicine, Shinshu University 2013 Professor Emeritus of Jichi Medical University (to present) Vice President of International University of Health and Welfare 2014 Director of Japanese Medical Specialty Board (part-time) 2015 Vice President of International University of Health and Welfare and Head of IUHW Hospital 2017 Chief Medical Officer of Ryoumou Seishi Ryogoen, Kiryu Ryoiku Futabakai Social Welfare Corporation 2018 Regent of Tokyo Medical University (part-time) (to present) 2020 Director of the Company (to present) 2024 Invited Professor of School of Medicine, Shinshu University (to present)
OutsideIndependent	Dr. Fumio Tateishi Honorary Advisor of OMRON Corporation Profile Date of Birth July 6, 1949 1975 Joined Tateisi Electronics Co. (currently OMRON Corporation) 1997 Director of OMRON Corporation (“OMRON”) 1999 Managing Executive Officer of OMRON 2001 Senior General Manager, Corporate Strategic Planning HQ of OMRON 2003 Executive Officer and Executive Vice President of OMRON President, Industrial Automation Business Company of OMRON 2008 Director and Executive Vice Chairman of OMRON 2013 Chairman of the Board of OMRON 2023 Director of the Company (to present) Honorary Advisor of OMRON (to present)
OutsideIndependent	Hideo Teramoto President of Dai-ichi Life Research Institute, Inc. Outside Director of Imperial Hotel, Ltd. Profile Date of Birth May 20,1960 1983 Joined The Dai-ichi Mutual Life Insurance Company 2012 Director, Managing Executive Officer, Deputy Chief General Manager of Group Management Headquarters, and General Manager of Corporate Planning Department of The Dai-ichi Life Insurance Company, Limited. (“DLI”) 2013 Director, Managing Executive Officer, and Deputy Chief General Manager of Group Management Headquarters of DLI 2015 Director, Senior Managing Executive Officer, and General Manager of Marketing Promotion of DLI 2016 Director, Senior Managing Executive Officer, and General Manager of Marketing Promotion of Dai-ichi Life Holdings, Inc. (“DLH”) Director and Senior Managing Executive Officer of DLI 2017 Director of DLH Representative Director and Vice Chairman of DLI 2020 Director, Vice Chairman, and General Manager of Innovation Strategy Unit of DLH 2021 Representative Director, Vice Chairman, and Executive Officer of DLH 2022 Director of DLH President of Dai-ichi Life Research Institute, Inc. (to present) 2023 Director of the Company (to present) Outside Director of Imperial Hotel, Ltd. (to present)
	Thomas Schinecker Roche Group, CEO Profile Date of Birth April 23, 1975 2003 Joined Roche Group 2005 Head of Marketing and Sales of Roche Diagnostics Austria 2008 General Manager of Roche Diagnostics Sweden 2011 Lifecycle Leader Sequencing Solutions of Roche Diagnostics 2013 General Manager of Roche Diagnostics Germany 2018 Global Head of Roche Diagnostics Centralised and Point of Care Solutions of Roche Diagnostics 2019 CEO of Roche Diagnostics Member of the Corporate Executive Committee (to present) 2023 CEO ad interim of Roche Pharma CEO of Roche Group (to present) 2025 Director of the Company (to present)
	Teresa A. Graham CEO of Roche Pharmaceuticals Member of the Roche Corporate Executive Committee Profile Date of Birth December 30, 1973 2005 Joined Genentech, Inc. as Product Manager 2010 Sales Manager of Genentech 2011 Marketing Director of Genentech 2013 Senior Director, Field Reimbursement Management of Genentech 2015 Lifecycle Leader, ACTEMRA of Roche 2017 Vice President, Rheumatology / Nephrology of Genentech 2018 Vice President, Avastin, Alecensa, Tarceva and Entrectinib, Lung & GI Oncology Sales of Genentech 2019 Head of Global Product Strategy of Roche Pharmaceuticals 2023 CEO of Roche Pharmaceuticals Member of the Corporate Executive Committee (to present) Director of the Company (to present)
	Boris L. Zaïtra Head of Corporate Business Development of Roche Member of the enlarged Corporate Executive Committee Profile Date of Birth April 24, 1972 1995 Mergers & Acquisitions, Associate of JP Morgan 1999 Duke Street Capital, Partner 2005 Head of Mergers & Acquisitions, Corporate Vice-President of Airbus Group 2012 Head of Group Business Development/M&A of Roche 2024 Head of Corporate Business Development of Roche (to present) Member of the enlarged Corporate Executive Committee (to present) 2025 Director of the Company (to present)

Audit & Supervisory Board Members

	Dr. Shigehiro Yamada Audit & Supervisory Board Member (full-time) Profile Date of Birth August 5, 1964 2005 Joined the Company 2016 Department Manager of PT Planning Dept. 2018 Department Manager of Corporate Planning Dept. of Chugai Pharma Manufacturing Co., Ltd. 2019 Head of Corporate Social Responsibility Dept. Head of Sustainability Dept. 2023 Audit & Supervisory Board Member (to present)
	Masayoshi Higuchi Audit & Supervisory Board Member (full-time) Profile Date of Birth April 17, 1969 1992 Joined the Company 2013 Head of Regulatory Affairs Department of the Company 2019 Head of Quality & Regulatory Compliance Strategy Department of the Company 2021 Head of Quality & Regulatory Compliance Unit of the Company 2022 Vice President, Head of Quality & Regulatory Compliance Unit of the Company 2023 Vice President, Head of Quality & Regulatory Compliance Unit, In charge of Risk & Compliance Department of the Company 2025 Vice President of the Company (to present)
OutsideIndependent	Kenichi Masuda Partner of Anderson Mōri & Tomotsune Outside Director of Bridgestone Corporation Outside Audit & Supervisory Board Member of Mercuria Holdings Co., Ltd. Profile Date of Birth January 11, 1963 1988 Registered as an attorney-at-law (Daini Tokyo Bar Association) Joined Anderson Mōri & Tomotsune 1993 Registered as an attorney-at-law in the state of New York 1997 Partner of Anderson Mōri & Tomotsune (to present) 2007 Outside Corporate Auditor of LIFENET INSURANCE COMPANY 2010 Part-time Lecturer at School of Law, The University of Tokyo 2011 Outside Corporate Auditor of Bridgestone Corporation 2016 Outside Director of Bridgestone Corporation (to present) Outside Audit & Supervisory Board Member of Mercuria Holdings Co., Ltd. (formerly Mercuria Investment Co., Ltd.) 2019 Visiting Professor of School of Law, The University of Tokyo 2020 Outside Audit & Supervisory Board Member of the Company (to present) 2025 Outside Director (Audit and Supervisory Committee Member) of Mercuria Holdings Co., Ltd. (to present)
OutsideIndependent	Yumiko Waseda Partner Attorney-at-Law/Partner Patent Attorney, Tokyo Roppongi Law and Patent Office Outside Audit & Supervisory Board Member of IHI Corporation Profile Date of Birth January 29, 1960 1985 Joined Matsuda Masayuki Law & Patent Office (currently Mori Hamada & Matsumoto) 2004 Vice President of Daini Tokyo Bar Association 2005 Executive Governor of Japan Federation of Bar Associations 2013 Joined Tokyo Roppongi Law & Patent Office 2014 Partner of Tokyo Roppongi Law & Patent Office (present) Outside Audit & Supervisory Board Member of Kao Corporation 2015 Outside Audit & Supervisory Board Member of Asahi Group Holdings, Ltd. 2016 President of Daini Tokyo Bar Association Vice President of Japan Federation of Bar Associations 2021 Outside Audit & Supervisory Board Member of IHI Corporation (to present) 2023 Outside Audit & Supervisory Board Member of the Company (to present) Director (Audit and Supervisory Committee Member) of SCSK Corporation (to present)
OutsideIndependent	Mami Yunoki Representative of Mami Yunoki Certified Public Accountant Office Profile Date of Birth May 27, 1963 1985 Joined Aoyama Audit Corporation 2006 Joined Arata Audit Corporation (currently PricewaterhouseCoopers Japan LLC) 2008 Partner of PricewaterhouseCoopers Arata (“Arata”) 2016 Member of the firm management committee and executive officer in charge of the manufacturing, distribution, and services division of Arata 2023 Representative of Mami Yunoki Certified Public Accountant Office (to present) 2024 Outside Audit & Supervisory Board Member of the Company (to present) Outside Director (Member of the Board) of Daiwa Securities Group Inc. (to present)

Executive Officers

Shinji Hidaka: Executive Vice President
Supervisory responsibility for Marketing & Sales, Drug Safety, Medical Affairs, PHC Solution and Special Mission for Overseas Marketing
Yoshiyuki Yano: Executive Vice President
Supervisory responsibility for Human Resource Management and ESG
In charge of Human Resources Management Dept. and ESG Dept.
Tsukasa Kusano: Executive Vice President
Supervisory responsibility for Project & Lifecycle Management and Partnering
Head of Project & Lifecycle Management Unit
In charge of Partnering Dept.
Dr. Kaori Ouchi: Executive Vice President
Supervisory responsibility for Risk Management, Compliance and Quality & Regulatory Compliance, Pharmaceutical Technology, Manufacturing Technology
In charge of Risk & Compliance Dept.
Norihisa Onozawa: Executive Vice President
Supervisory responsibility for Corporate Planning, ASPIRE Transformation and Digital Transformation
Head of Corporate Planning Dept.
In charge of ASPIRE Transformation Dept.
Shoko Kimijima: Executive Vice President
Supervisory responsibility for Legal and Intellectual Property
In charge of Legal Dept. and Intellectual Property Dept.
Shinya Takuma: Vice President
Head of Manufacturing Technology Div.
Naoya Fujihara: Vice President
In charge of External Affairs Dept.
Dr. Tomoyuki Igawa: Vice President
Head of Research Div.